Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis

被引:59
作者
Ozalevli, Sevgi [1 ]
Karaali, Hayriye Kul [1 ]
Ilgin, Duygu [1 ]
Ucan, Eyup Sabri [2 ]
机构
[1] Dokuz Eylul Univ, Sch Phys Therapy & Rehabil, Izmir, Turkey
[2] Dokuz Eylul Univ, Dept Chest Dis, Izmir, Turkey
关键词
Exercise capacity; home-based pulmonary rehabilitation; idiopathic pulmonary fibrosis; quality of life; INTERSTITIAL LUNG-DISEASE; QUALITY-OF-LIFE; EXERCISE; DYSPNEA; SF-36;
D O I
10.1186/2049-6958-5-1-31
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: The aim of this study was to investigate the effects of a home-based pulmonary rehabilitation program on the functional outcome parameters in patients with idiopathic pulmonary fibrosis (IPF). Design: A prospective study. Patients: Seventeen patients diagnosed with IPF. Methods: A home-based pulmonary rehabilitation program was carried out in 17 IPF patients for 12 weeks. Dyspnea severity during daily life activities (Medical Research Council Scale), pulmonary function (pulmonary function test), exercise capacity (6-minute walking test, 6MWD), and general health related quality of life (Medical Outcomes Short Form-36) were evaluated. Results: A significant decrease in perceived dyspnea (p = 0.003) and leg fatigue (p < 0.05) severities, and an increase in the 6MWD (p = 0.04) and general health related quality of life scores (health perception, physical role, and emotional status subscores) were found after the program (p < 0.05). Conclusion: Home-based pulmonary rehabilitation may reduce dyspnea and fatigue severities, and improve exercise capacity and health-related quality of life in patients with IPF. In the treatment of IPF patients, home-based pulmonary rehabilitation programs should be placed alongside the routine treatment options.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 25 条
[2]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
[3]   Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[4]   VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE [J].
BRAZIER, JE ;
HARPER, R ;
JONES, NMB ;
OCATHAIN, A ;
THOMAS, KJ ;
USHERWOOD, T ;
WESTLAKE, L .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846) :160-164
[5]   Assessment of health-related quality of life in patients with interstitial lung disease [J].
Chang, JA ;
Curtis, JR ;
Patrick, DL ;
Raghu, G .
CHEST, 1999, 116 (05) :1175-1182
[6]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[7]   Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population [J].
Demiral, Yucel ;
Ergor, Gul ;
Unal, Belgin ;
Semin, Semih ;
Akvardar, Yildiz ;
Kivircik, Berna ;
Alptekin, Koeksal .
BMC PUBLIC HEALTH, 2006, 6 (1)
[8]   Pulmonary Rehabilitation in Interstitial Lung Disease Benefits and Predictors of Response [J].
Ferreira, Alicia ;
Garvey, Chris ;
Connors, Gerilynn L. ;
Hilling, Lana ;
Rigler, Julia ;
Farrell, Susan ;
Cayou, Cindy ;
Shariat, Cyrus ;
Collard, Harold R. .
CHEST, 2009, 135 (02) :442-447
[9]   Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease [J].
Holland, A. E. ;
Hill, C. J. ;
Conron, M. ;
Munro, P. ;
McDonald, C. F. .
THORAX, 2008, 63 (06) :549-554
[10]  
Jastrzebski D, 2006, J PHYSIOL PHARMACOL, V57, P139